-
January 04, 2013
US Drug approvals in 2012 reach a 15-year high with regulators giving the thumbs up to 39 new drugs
Full story
-
January 02, 2013
US Food and Drug Administration approves two new drugs - one for multi-drug resistant TB and the other for stroke prevention
Full story
-
August 10, 2012
The US Food and Drug Administration has given the green light to Talon Therapeutics’ orphan drug Marqibo to treat a rare type of leukaemia after the drug was fast tracked through the agency’s accelerated approval programme.
Full story
-
August 01, 2012
The European Medicines Agency (EMA) reports that its levels of interaction and cooperation with the medicines regulatory authorities in Japan have increased over the past three years.
Full story
-
August 02, 2011
GlaxoSmithKline's recently-licensed Trobalt (retigabine) should be prescribed as an add-on treatment for adults with epilepsy if other drugs have been ineffective or produced unmanageable side effects, says final guidance from NICE.
Full story
-
June 07, 2011
Johnson & Johnson's Zytiga (abiraterone acetate) is set to earn peak-year sales of $910 million in major world markets from its use in the treatment of metastatic castrate-resistant prostate cancer (MCRPC), according to new forecasts.
Full story